Holding(s) in Company

Allergy Therapeutics PLC
11 October 2007


TR-1:              NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing  Allergy Therapeutics plc
shares to which voting rights are attached:

2. Reason for the notification (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights                               X

An acquisition or disposal of financial instruments which may result in the acquisition of
shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification           Fidelity International Limited (FIL)
obligation:

4. Full name of shareholder(s) (if different from 3.):          See 9 below

5. Date of the transaction (and date on which the threshold is  8 October 2007
crossed or reached if different):

6. Date on which issuer notified:                               10 October 2007

7. Threshold(s) that is/are crossed or reached:                 11%

8. Notified details:


A: Voting rights attached to shares
Class/type of     Situation previous to  Resulting situation after the triggering transaction
shares            the Triggering
                  transaction
 if possible      Number of  Number of   Number of   Number of voting rights  % of voting rights
using the ISIN    Shares     Voting      shares
CODE                         Rights      Direct      Direct      Indirect     Direct       Indirect
GB00B02LCQ05      9,021,794  9,021,794   0           0           9,009,294    0.00%        10.99%

ORD £0.001


B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial    Expiration date Exercise/ Conversion      Number of voting rights    % of voting
instrument                           Period/ Date              that may be acquired if    rights
                                                               the instrument is
                                                               exercised/ converted
N/A                  N/A             N/A                       N/A                        N/A


Total (A+B)
Number of voting rights                            % of voting rights

9,009,294                                          10.99%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively
held, if applicable:

Fidelity International Limited (FIL) is the parent holding company for various direct and indirect subsidiaries,
including Fidelity Fund Management Limited (FFML), Fidelity Investment Services Ltd (FISL), Fideilty Gestion (FIGEST),
Fideilty Investments Advisory (Korea) Limited (FIAKL), Fidelity Investments Management (Hong Kong) Limited (FIMHK),
Fidelity Pension Management (FPM), Fidelity Investments Japan (FIJ) and Fidelity Investments International (FII),
investment managers for various non-US investment companies and institutional clients.

UK Nominee                          Management Company                  Shares Held
Bank of New York, Brussels          FPM                                 158,200
Brown Bros Harrimn Ltd Lux          FIL                                 237,533
JP Morgan, Bournemouth              FII                                 831,000
JP Morgan, Bournemouth              FIL                                 861,679
JP Morgan, Bournemouth              FISL                                5,597,098
JP Morgan, Bournemouth              FPM                                 675,100
Northern Trust London               FPM                                 612,700
State Str Bk and Tr Co LNDN         FPM                                 35,984

Total                                                                   9,009,294



Proxy Voting:

10. Name of the proxy holder:                                      Fidelity International Limited (FIL)

11. Number of voting rights proxy holder will cease to hold:       12,500

12. Date on which proxy holder will cease to hold voting rights:   8 October 2007




                      This information is provided by RNS
            The company news service from the London Stock Exchange